Syneos Health, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2014 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Syneos Health, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q1 2023.
- Syneos Health, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was -$12.1M, a 1305% decline year-over-year.
- Syneos Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.86M, a 104% decline from 2021.
- Syneos Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $46.5M.
- Syneos Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2020 was -$3.84M, a 90.4% increase from 2019.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)